These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 29114733

  • 1. Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial.
    Büchele F, Hackius M, Schreglmann SR, Omlor W, Werth E, Maric A, Imbach LL, Hägele-Link S, Waldvogel D, Baumann CR.
    JAMA Neurol; 2018 Jan 01; 75(1):114-118. PubMed ID: 29114733
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
    Sleep; 2002 Feb 01; 25(1):42-9. PubMed ID: 11833860
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy.
    Roth T, Dauvilliers Y, Guinta D, Alvarez-Horine S, Dynin E, Black J.
    J Sleep Res; 2017 Aug 01; 26(4):407-414. PubMed ID: 27807903
    [Abstract] [Full Text] [Related]

  • 8. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J, Swick T, Bogan R, Lai C, Carter LP.
    Sleep Med; 2016 Aug 01; 24():57-62. PubMed ID: 27810187
    [Abstract] [Full Text] [Related]

  • 9. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
    Xyrem International Study Group.
    J Clin Sleep Med; 2005 Oct 15; 1(4):391-7. PubMed ID: 17564408
    [Abstract] [Full Text] [Related]

  • 10. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
    Högl B, Saletu M, Brandauer E, Glatzl S, Frauscher B, Seppi K, Ulmer H, Wenning G, Poewe W.
    Sleep; 2002 Dec 15; 25(8):905-9. PubMed ID: 12489899
    [Abstract] [Full Text] [Related]

  • 11. Melatonin Supplementation for Children With Atopic Dermatitis and Sleep Disturbance: A Randomized Clinical Trial.
    Chang YS, Lin MH, Lee JH, Lee PL, Dai YS, Chu KH, Sun C, Lin YT, Wang LC, Yu HH, Yang YH, Chen CA, Wan KS, Chiang BL.
    JAMA Pediatr; 2016 Jan 15; 170(1):35-42. PubMed ID: 26569624
    [Abstract] [Full Text] [Related]

  • 12. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J, Pardi D, Hornfeldt CS, Inhaber N.
    Sleep Med; 2009 Sep 15; 10(8):829-35. PubMed ID: 19616998
    [Abstract] [Full Text] [Related]

  • 13. Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson's disease.
    Liguori C, Mercuri NB, Albanese M, Olivola E, Stefani A, Pierantozzi M.
    J Neurol; 2019 Mar 15; 266(3):636-641. PubMed ID: 30607535
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study.
    Dauvilliers Y, Arnulf I, Foldvary-Schaefer N, Morse AM, Šonka K, Thorpy MJ, Mignot E, Chandler P, Parvataneni R, Black J, Sterkel A, Chen D, Skobieranda F, Bogan RK.
    Lancet Neurol; 2022 Jan 15; 21(1):53-65. PubMed ID: 34942138
    [Abstract] [Full Text] [Related]

  • 15. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.
    Plazzi G, Ruoff C, Lecendreux M, Dauvilliers Y, Rosen CL, Black J, Parvataneni R, Guinta D, Wang YG, Mignot E.
    Lancet Child Adolesc Health; 2018 Jul 15; 2(7):483-494. PubMed ID: 30169321
    [Abstract] [Full Text] [Related]

  • 16. Enhancing slow wave sleep with sodium oxybate reduces the behavioral and physiological impact of sleep loss.
    Walsh JK, Hall-Porter JM, Griffin KS, Dodson ER, Forst EH, Curry DT, Eisenstein RD, Schweitzer PK.
    Sleep; 2010 Sep 15; 33(9):1217-25. PubMed ID: 20857869
    [Abstract] [Full Text] [Related]

  • 17. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
    Black J, Pardi D, Hornfeldt CS, Inhaber N.
    J Clin Sleep Med; 2010 Dec 15; 6(6):596-602. PubMed ID: 21206549
    [Abstract] [Full Text] [Related]

  • 18. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy.
    Mamelak M, Black J, Montplaisir J, Ristanovic R.
    Sleep; 2004 Nov 01; 27(7):1327-34. PubMed ID: 15586785
    [Abstract] [Full Text] [Related]

  • 19. A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome.
    George CF, Feldman N, Zheng Y, Steininger TL, Grzeschik SM, Lai C, Inhaber N.
    Sleep Breath; 2011 Jan 01; 15(1):13-20. PubMed ID: 20082240
    [Abstract] [Full Text] [Related]

  • 20. Rasagiline improves polysomnographic sleep parameters in patients with Parkinson's disease: a double-blind, baseline-controlled trial.
    Schrempf W, Fauser M, Wienecke M, Brown S, Maaß A, Ossig C, Otto K, Brandt MD, Löhle M, Schwanebeck U, Graehlert X, Reichmann H, Storch A.
    Eur J Neurol; 2018 Apr 01; 25(4):672-679. PubMed ID: 29322594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.